Please use this identifier to cite or link to this item:
Title: Role of hydrogen sulphide in ischemic disease: possible interactions with carbon monoxide
Keywords: hydrogen sulphide, carbon monoxide, ischemic disease
Issue Date: 3-Mar-2008
Citation: LOKE YOKE YUN (2008-03-03). Role of hydrogen sulphide in ischemic disease: possible interactions with carbon monoxide. ScholarBank@NUS Repository.
Abstract: The role and possible interactions of hydrogen sulphide (H2S) with carbon monoxide (CO) in ischemic disease has not been previously studied. Thus we investigated whether H2S works synergistically with CO in the amelioration of myocardial infarction (MI) in vitro with a hypoxic environment. From the cell viability data, it was shown that cell death was eradicated with pretreatment of NaHS (54.0B10.8%) or CORM-2 (55.0B10.8%) individually. Interestingly, the cell viability improved several folds when both NaHS and CORM-2 (91.2B11.6%) were administered (P<0.05 compared to HC). The cell viability test was correlated to the lactate dehydrogenase (LDH) assay, H2S assay, cystathionine-gamma-lyase (CSE) activity, heme oxygenase (HO) activity and immunohistochemical staining. As for reverse transcription polymerase chain reaction (RT-PCR) on CSE and HO-1 genes, the mRNA level in the NaHS and CORM-2 pretreatment group was several folds higher compared to NaHS or CORM-2 only pretreated groups.
Appears in Collections:Master's Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
Loke Yoke Yun (HT050796Y).pdf744.95 kBAdobe PDF



Page view(s)

checked on Sep 29, 2018


checked on Sep 29, 2018

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.